Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Vaccine. 2003 May 1;21(16):1789-95.

Novel generations of influenza vaccines.

Author information

  • 1MedImmune Vaccines, 297 North Bernardo Avenue, Mountain View, CA 94043, USA. kembleg@medimmune.com

Abstract

Several strategies are being pursued to increase the quality and quantity of influenza vaccines that are used on an annual basis including increasing the immunogenicity of currently licensed inactivated vaccines, delivery of inactive vaccines directly to the nasal mucosa, the use of cell lines for virus production and the use of live, attenuated vaccines. In addition, modern molecular biological techniques are being used to create and evaluate new vaccine approaches. This report will briefly review these different strategies and outline some of the potential advantages and challenges associated with them.

PMID:
12686096
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk